Frontiers in medicine · 2025
Efficacy of budesonide suspension in the treatment of lobar pneumonia by fiberoptic bronchoscopic alveolar lavage.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ji Xin, Fu Hongjie, Zhang Fang, Chen Na, Xing Xiugui, Ji Jinghua, Zhou Tian, Song Xiangqin
Аннотация
OBJECTIVE: To probe the efficacy of budesonide suspension in treating lobar pneumonia by fiberoptic bronchoscopic alveolar lavage.
METHODS: A total of 176 preschool and school-age children with lobar pneumonia in the pediatric respiratory department of Binzhou Medical University Hospital from December 2020 to December 2021 were selected and divided into observation group (OG, n = 88) and control group (CG, n = 88) based on the wishes of their families. Children in both groups were given azithromycin sequential treatment. The CG was given fiberoptic bronchoscope alveolar lavage with sodium chloride injection, and the OG was treated with fiberoptic bronchoscope alveolar lavage with sodium chloride injection + inhalation of budesonide suspension. The treatment, inflammatory factor levels, immune function, lung function indicators, adverse reactions and clinical efficacy were compared between both groups.
RESULTS: The total effective rate of the OG was 90.91%, which was better than 81.82% of the CG (χ 2 = 3.095, p < 0.05). After treatment, the serum IL-6, CRP and ESR levels declined, and IL-2 level was elevated in the OG relative to the CG (p < 0.05). The levels of IgM, IgA, IgG, FVC, FEV1, PEF, FEF25, FEF50, FEF75 and FEF25-75 in the OG were enhanced compared to the CG (p < 0.05). The antipyrexia time, the disappearance time of lung shadow, the improvement time of cough and expectoration, and the disappearance time of lung rales in the OG were shorter compared to the CG (p < 0.05).
CONCLUSION: Budesonide combined with fiberoptic bronchoscopy lavage in treating lobar pneumonia in children with Mycoplasma pneumoniae is effective in enhancing the therapeutic effect, relieving the clinical symptoms and signs of children faster, significantly reducing the inflammatory response, and significantly improving lung function. It is safe, effective and has no adverse reactions.
METHODS: A total of 176 preschool and school-age children with lobar pneumonia in the pediatric respiratory department of Binzhou Medical University Hospital from December 2020 to December 2021 were selected and divided into observation group (OG, n = 88) and control group (CG, n = 88) based on the wishes of their families. Children in both groups were given azithromycin sequential treatment. The CG was given fiberoptic bronchoscope alveolar lavage with sodium chloride injection, and the OG was treated with fiberoptic bronchoscope alveolar lavage with sodium chloride injection + inhalation of budesonide suspension. The treatment, inflammatory factor levels, immune function, lung function indicators, adverse reactions and clinical efficacy were compared between both groups.
RESULTS: The total effective rate of the OG was 90.91%, which was better than 81.82% of the CG (χ 2 = 3.095, p < 0.05). After treatment, the serum IL-6, CRP and ESR levels declined, and IL-2 level was elevated in the OG relative to the CG (p < 0.05). The levels of IgM, IgA, IgG, FVC, FEV1, PEF, FEF25, FEF50, FEF75 and FEF25-75 in the OG were enhanced compared to the CG (p < 0.05). The antipyrexia time, the disappearance time of lung shadow, the improvement time of cough and expectoration, and the disappearance time of lung rales in the OG were shorter compared to the CG (p < 0.05).
CONCLUSION: Budesonide combined with fiberoptic bronchoscopy lavage in treating lobar pneumonia in children with Mycoplasma pneumoniae is effective in enhancing the therapeutic effect, relieving the clinical symptoms and signs of children faster, significantly reducing the inflammatory response, and significantly improving lung function. It is safe, effective and has no adverse reactions.